This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nie, Z.
Right arrow Articles by Cohen, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nie, Z.
Right arrow Articles by Cohen, E. A.

 Previous Article  |  Next Article 

J Virol, May 1998, p. 4104-4115, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

The Putative Alpha Helix 2 of Human Immunodeficiency Virus Type 1 Vpr Contains a Determinant Which Is Responsible for the Nuclear Translocation of Proviral DNA in Growth-Arrested Cells

Zilin Nie, Dominique Bergeron, Ramu A. Subbramanian, Xiao-Jian Yao, Florent Checroune, Nicole Rougeau, and Eric A. Cohen*

Département de Microbiologie et Immunologie, Faculté de Médecine, Université de Montréal, Montréal, Québec, Canada H3C 3J7

Received 7 October 1997/Accepted 3 February 1998

Several viral determinants were shown to play a role in the ability of human immunodeficiency virus type 1 (HIV-1) to infect nondividing cells. In particular, Vpr and Gag matrix (MA) were recognized to be involved in the nuclear transport of the viral preintegration complex. The goal of the present study was to evaluate the ability of isogenic HIV-1 viruses harboring different vpr and gag genes to infect nondividing cells. Surprisingly, our results reveal that the introduction of mutations in the MA nuclear localization signal marginally affected the ability of proviruses to establish infection in growth-arrested HeLa or MT4 cells. In contrast, we show that in our experimental system, the absence of Vpr expression leads to a reduction in viral infectivity and production which correlates with a decrease in the synthesis and nuclear transport of proviral DNA as determined by PCR analysis. Moreover, our data demonstrate that this reduction of viral replication is also observed with proviruses containing different mutated Vpr alleles. In particular, the Vpr Q65E mutant, which contains a substitution in the second predicted amphipathic alpha-helical structure located in the central region of the protein, is associated with an impairment of the protein nuclear localization and a concomitant reduction of the nuclear transport of proviral DNA. The results of this study provide evidence that a putative amphipathic alpha-helical structure in the central region of Vpr contains a determinant involved in the nuclear translocation of the preintegration complex in nondividing cells.


* Corresponding author. Mailing address: Laboratoire de Rétrovirologie Humaine, Département de Microbiologie et Immunologie, Faculté de Médecine, Université de Montréal, C.P. 6128, Succursale Centre-ville, Montréal, Québec, Canada H3C 3J7. Phone: (514) 343-5967. Fax: (514) 343-5995. E-mail: cohenea{at}ere.umontreal.ca.


J Virol, May 1998, p. 4104-4115, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Mishra, S., Mishra, J. P., Kumar, A. (2007). Activation of JNK-dependent Pathway Is Required for HIV Viral Protein R-induced Apoptosis in Human Monocytic Cells: INVOLVEMENT OF ANTIAPOPTOTIC BCL2 AND c-IAP1 GENES. J. Biol. Chem. 282: 4288-4300 [Abstract] [Full Text]  
  • Jin, S., Chen, C., Montelaro, R. C. (2005). Equine Infectious Anemia Virus Gag p9 Function in Early Steps of Virus Infection and Provirus Production. J. Virol. 79: 8793-8801 [Abstract] [Full Text]  
  • Kamata, M., Nitahara-Kasahara, Y., Miyamoto, Y., Yoneda, Y., Aida, Y. (2005). Importin-{alpha} Promotes Passage through the Nuclear Pore Complex of Human Immunodeficiency Virus Type 1 Vpr. J. Virol. 79: 3557-3564 [Abstract] [Full Text]  
  • Iordanskiy, S., Zhao, Y., DiMarzio, P., Agostini, I., Dubrovsky, L., Bukrinsky, M. (2004). Heat-shock protein 70 exerts opposing effects on Vpr-dependent and Vpr-independent HIV-1 replication in macrophages. Blood 104: 1867-1872 [Abstract] [Full Text]  
  • Ao, Z., Yao, X., Cohen, E. A. (2004). Assessment of the Role of the Central DNA Flap in Human Immunodeficiency Virus Type 1 Replication by Using a Single-Cycle Replication System. J. Virol. 78: 3170-3177 [Abstract] [Full Text]  
  • Sherman, M. P., de Noronha, C. M. C., Eckstein, L. A., Hataye, J., Mundt, P., Williams, S. A. F., Neidleman, J. A., Goldsmith, M. A., Greene, W. C. (2003). Nuclear Export of Vpr Is Required for Efficient Replication of Human Immunodeficiency Virus Type 1 in Tissue Macrophages. J. Virol. 77: 7582-7589 [Abstract] [Full Text]  
  • Coeytaux, E., Coulaud, D., Le Cam, E., Danos, O., Kichler, A. (2003). The Cationic Amphipathic alpha -Helix of HIV-1 Viral Protein R (Vpr) Binds to Nucleic Acids, Permeabilizes Membranes, and Efficiently Transfects Cells. J. Biol. Chem. 278: 18110-18116 [Abstract] [Full Text]  
  • Altfeld, M., Addo, M. M., Eldridge, R. L., Yu, X. G., Thomas, S., Khatri, A., Strick, D., Phillips, M. N., Cohen, G. B., Islam, S. A., Kalams, S. A., Brander, C., Goulder, P. J. R., Rosenberg, E. S., Walker, B. D. (2001). Vpr Is Preferentially Targeted by CTL During HIV-1 Infection. J. Immunol. 167: 2743-2752 [Abstract] [Full Text]  
  • McKnight, A., Griffiths, D. J., Dittmar, M., Clapham, P., Thomas, E. (2001). Characterization of a Late Entry Event in the Replication Cycle of Human Immunodeficiency Virus Type 2. J. Virol. 75: 6914-6922 [Abstract] [Full Text]  
  • Sherman, M. P., de Noronha, C. M. C., Heusch, M. I., Greene, S., Greene, W. C. (2001). Nucleocytoplasmic Shuttling by Human Immunodeficiency Virus Type 1 Vpr. J. Virol. 75: 1522-1532 [Abstract] [Full Text]  
  • Singh, S. P., Tomkowicz, B., Lai, D., Cartas, M., Mahalingam, S., Kalyanaraman, V. S., Murali, R., Srinivasan, A. (2000). Functional Role of Residues Corresponding to Helical Domain II (Amino Acids 35 to 46) of Human Immunodeficiency Virus Type 1 Vpr. J. Virol. 74: 10650-10657 [Abstract] [Full Text]  
  • Conti, L., Matarrese, P., Varano, B., Gauzzi, M. C., Sato, A., Malorni, W., Belardelli, F., Gessani, S. (2000). Dual Role of the HIV-1 Vpr Protein in the Modulation of the Apoptotic Response of T Cells. J. Immunol. 165: 3293-3300 [Abstract] [Full Text]  
  • Kamata, M., Aida, Y. (2000). Two Putative alpha -Helical Domains of Human Immunodeficiency Virus Type 1 Vpr Mediate Nuclear Localization by at Least Two Mechanisms. J. Virol. 74: 7179-7186 [Abstract] [Full Text]  
  • Hrimech, M., Yao, X.-J., Bachand, F., Rougeau, N., Cohen, E. A. (1999). Human Immunodeficiency Virus Type 1 (HIV-1) Vpr Functions as an Immediate-Early Protein during HIV-1 Infection. J. Virol. 73: 4101-4109 [Abstract] [Full Text]  
  • Chen, M., Elder, R. T., Yu, M., O'Gorman, M. G., Selig, L., Benarous, R., Yamamoto, A., Zhao, Y. (1999). Mutational Analysis of Vpr-Induced G2 Arrest, Nuclear Localization, and Cell Death in Fission Yeast. J. Virol. 73: 3236-3245 [Abstract] [Full Text]  
  • Bachand, F., Yao, X.-J., Hrimech, M., Rougeau, N., Cohen, E. A. (1999). Incorporation of Vpr into Human Immunodeficiency Virus Type 1 Requires a Direct Interaction with the p6 Domain of the p55 Gag Precursor. J. Biol. Chem. 274: 9083-9091 [Abstract] [Full Text]  
  • Bukrinskaya, A., Brichacek, B., Mann, A., Stevenson, M. (1998). Establishment of a Functional Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcription Complex Involves the Cytoskeleton. JEM 188: 2113-2125 [Abstract] [Full Text]  
  • Henklein, P., Bruns, K., Sherman, M. P., Tessmer, U., Licha, K., Kopp, J., de Noronha, C. M. C., Greene, W. C., Wray, V., Schubert, U. (2000). Functional and Structural Characterization of Synthetic HIV-1 Vpr That Transduces Cells, Localizes to the Nucleus, and Induces G2 Cell Cycle Arrest. J. Biol. Chem. 275: 32016-32026 [Abstract] [Full Text]